TY - JOUR
T1 - Farmakologisk hypertensionsbehandling
AU - Pedersen, Ole Lederballe
AU - Christensen, Kent Lodberg
AU - Bang, Lia E
AU - Ibsen, Hans
AU - Schultz-Larsen, Peter
N1 - Keywords: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Thiazides
PY - 2009
Y1 - 2009
N2 - Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic.
Udgivelsesdato: 2009-Jun-8
AB - Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic.
Udgivelsesdato: 2009-Jun-8
M3 - Tidsskriftartikel
C2 - 19523367
VL - 171
SP - 2022
EP - 2025
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 24
ER -